05/08/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:07 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:51 PM | CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024
5:04 AM | Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024
6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
|
03/27/2024
10:55 AM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024
8:04 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
11:13 AM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
12:56 PM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
10:58 AM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
3:18 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:19 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:20 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Marinus Pharmaceuticals (Issuer)
Nochur Sara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:25 PM | Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:26 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:28 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:04 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:31 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:11 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:55 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:10 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
8:05 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
America’s worst nightmare? (Ad) What This Group Has Planned for the 2024 Election Will Shock You
Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. |
08/08/2023
8:05 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
7:45 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
8:02 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2023
8:08 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
